114 studies found for:    NIAID | Open Studies | Exclude Unknown | Acquired Immunodeficiency Syndrome OR Human Immunodeficiency Virus OR chlamydia OR genital herpes OR gonorrhea OR pelvic inflammatory
Show Display Options
Download search resultsDownload the search results for:
NIAID | Open Studies | Exclude Unknown | Acquired Immunodeficiency Syndrome OR Human Immunodeficiency Virus OR chlamydia OR genital herpes OR gonorrhea OR pelvic inflammatory (114 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
Conditions: Acquired Immune Deficiency Syndrome Virus;   Acquired Immunodeficiency Syndrome Virus;   AIDS Virus;   Human Immunodeficiency Virus;   Human Immunodeficiency Viruses
Intervention:
2 Recruiting Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition: Human Immunodeficiency Virus
Intervention:
3 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: rVSV;   Biological: IL-12 pDNA adjuvant;   Biological: HIV-Mag pDNA
4 Recruiting Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Conditions: Blood Component Removal;   Human Immunodeficiency Virus
Intervention:
5 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: HIV Infection
Interventions: Drug: Aspirin 81 mg daily;   Drug: Atorvastatin 40 mg daily
6 Recruiting Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons
Condition: HIV Infection
Intervention:
7 Recruiting VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...
Conditions: HIV-1 Infection;   Neutralizing Antibody;   Monoclonal Antibody;   Viral Load;   HIV Antibodies
Intervention: Biological: VRC-HIVMAB060-00-AB
8 Recruiting Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
Condition: HIV
Intervention:
9 Recruiting Clinical Outcomes in Persons With HIV Acquired Early in Life
Conditions: HIV;   Childhood;   Natural History;   Cardiac;   ART
Intervention:
10 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
11 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Condition: Tuberculosis
Intervention:
12 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
13 Recruiting Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
Conditions: Liver Disease;   Steatohepatitis;   HIV
Intervention:
14 Recruiting Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Condition: HIV
Intervention:
15 Recruiting HIV Accelerated Liver Disease in Uganda
Condition: Fibrosis
Intervention:
16 Recruiting Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
Condition: HIV Infection
Intervention:
17 Recruiting Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
Conditions: Immunodeficiency;   Mycobacterial Infection;   Opportunistic Infection
Intervention:
18 Recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
19 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
20 Recruiting A Safety and Immune Response Study of 2 Experimental HIV Vaccines
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: Bivalent Subtype C gp120/MF59®;   Biological: ALVAC-HIV (vCP2438) Placebo;   Biological: Bivalent gp120/MF59® Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years